Lamotrigine Therapy in Neuronal Lipofuscinosis
Abstract
Lamotrigine (LTG) long-term anticonvulsant therapy was evaluated in 29 patients, aged 6-28 years (mean, 14 years), with juvenile neuronal ceroid lipofuscinosis (JNCL), followed for 1-6 years (mean, 3 years) at the Hospital for Children and Adolescents, University of Helsinki, Finland.
DOI: https://doi.org/10.15844/pedneurbriefs-13-8-6 | Journal eISSN: 2166-6482
Language: English
Page range: 60 - 60
Published on: Aug 1, 1999
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.